626 related articles for article (PubMed ID: 17265500)
41. [Anterior uveitis and juvenile idiopathic arthritis].
Vela JI; Galán A; Fernández E; Romera M; Torres JJ
Arch Soc Esp Oftalmol; 2003 Oct; 78(10):561-5. PubMed ID: 14569505
[TBL] [Abstract][Full Text] [Related]
42. [Diagnosis of rheumatoid uveitis in children and teenagers].
Denislam D; Constantin F
Oftalmologia; 2005; 49(2):75-81. PubMed ID: 16245748
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis.
Guillaume S; Prieur AM; Coste J; Job-Deslandre C
Arthritis Rheum; 2000 Aug; 43(8):1858-65. PubMed ID: 10943877
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
45. Current therapeutic approaches to autoimmune chronic uveitis in children.
Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
[TBL] [Abstract][Full Text] [Related]
46. [Eye complications in chronic juvenile arthritis].
Körner-Stiefbold U; Sauvain MJ; Gerber N; Garweg J; Körner F; Gugler E
Klin Monbl Augenheilkd; 1993 Apr; 202(4):269-80. PubMed ID: 8331883
[TBL] [Abstract][Full Text] [Related]
47. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
48. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.
Immonen K; Savolainen A; Kautiainen H; Hakala M
J Rheumatol; 2008 May; 35(5):907-12. PubMed ID: 18381779
[TBL] [Abstract][Full Text] [Related]
49. [Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database].
Minden K; Mingels A; Niewerth M; Heiligenhaus A; Ganser G
Klin Monbl Augenheilkd; 2007 Jun; 224(6):469-72. PubMed ID: 17594614
[TBL] [Abstract][Full Text] [Related]
50. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.
Nordal E; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Straume B; Rygg M;
Arthritis Rheum; 2011 Sep; 63(9):2809-18. PubMed ID: 21560116
[TBL] [Abstract][Full Text] [Related]
51. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
52. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
Spiegel LR; Schneider R; Lang BA; Birdi N; Silverman ED; Laxer RM; Stephens D; Feldman BM
Arthritis Rheum; 2000 Nov; 43(11):2402-9. PubMed ID: 11083261
[TBL] [Abstract][Full Text] [Related]
53. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
[TBL] [Abstract][Full Text] [Related]
54. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
55. Retrospective case review of pediatric patients with uveitis treated with infliximab.
Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
[TBL] [Abstract][Full Text] [Related]
56. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
[TBL] [Abstract][Full Text] [Related]
57. Ocular complications of pediatric uveitis.
Rosenberg KD; Feuer WJ; Davis JL
Ophthalmology; 2004 Dec; 111(12):2299-306. PubMed ID: 15582090
[TBL] [Abstract][Full Text] [Related]
58. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults.
Ozdal PC; Vianna RN; Deschênes J
Ocul Immunol Inflamm; 2005 Feb; 13(1):33-8. PubMed ID: 15804767
[TBL] [Abstract][Full Text] [Related]
59. Juvenile idiopathic arthritis.
Boros C; Whitehead B
Aust Fam Physician; 2010 Sep; 39(9):630-6. PubMed ID: 20877765
[TBL] [Abstract][Full Text] [Related]
60. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
